HealthCareTips blog: Timing Is Everything for Merck’s COVID Pill: If a result comes too late, or a test seems out of reach, then the sick person can easily miss that crucial early-infection window—a big loss, considering that molnupiravir has essentially “no effect on patients once they’re in hospitals,”

Timing Is Everything for Merck’s COVID Pill: If a result comes too late, or a test seems out of reach, then the sick person can easily miss that crucial early-infection window—a big loss, considering that molnupiravir has essentially “no effect on patients once they’re in hospitals,”

Timing Is Everything for Merck’s COVID Pill: If a result comes too late, or a test seems out of reach, then the sick person can easily miss that crucial early-infection window—a big loss, considering that molnupiravir has essentially “no effect on patients once they’re in hospitals,”

submitted by /u/shallah
[link] [comments]

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)